News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
NICHOL GEOFFREY
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/22/2022 |
4
| NICHOL GEOFFREY (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 3,500 options to buy
@ $2.08, valued at
$7.3k
|
|
| 07/06/2021 |
4
| NICHOL GEOFFREY (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,635 options to buy
@ $11.07, valued at
$73.4k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2015 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Paid exercise price by delivering 4,697 shares
@ $8.68, valued at
$40.8k
Paid exercise price by delivering 4,384 shares
@ $8.68, valued at
$38.1k
|
|
| 12/09/2015 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 37,500 shares
@ $0
Paid exercise price by delivering 6,889 shares
@ $9.69, valued at
$66.8k
Granted 75,000 options to buy
@ $9.41, valued at
$705.8k
|
|
| 12/15/2014 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 37,500 shares
@ $0
Paid exercise price by delivering 41,743 shares
@ $14.7382, valued at
$615.2k
Granted 75,000 options to buy
@ $14.07, valued at
$1.1M
|
|
| 12/13/2013 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 35,000 shares
@ $0
Paid exercise price by delivering 22,611 shares
@ $12.12, valued at
$274k
Granted 70,000 options to buy
@ $12.12, valued at
$848.4k
|
|
| 12/10/2012 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 55,000 shares
@ $0
Granted 110,000 options to buy
@ $5.41, valued at
$595.1k
|
|
| 12/12/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/11/2011 |
4
| NICHOL GEOFFREY (Executive Vice President, R&D) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 300,000 options to buy
@ $5.94, valued at
$1.8M
|
|
| 09/03/2009 |
4
| NICHOL GEOFFREY (Senior Vice President) has filed a Form 4 on MEDAREX INC|
Txns:
| Disposed/sold 55,904 options to buy
@ $7.16, valued at
$400.3k
Disposed/sold 17,841 options to buy
@ $5.61, valued at
$100.1k
Disposed/sold 10,101 options to buy
@ $9.9, valued at
$100k
Disposed/sold 200,000 options to buy
@ $5.25, valued at
$1.1M
Disposed/sold 144,096 options to buy
@ $7.16, valued at
$1M
Disposed/sold 167,159 options to buy
@ $5.61, valued at
$937.8k
Disposed/sold 239,899 options to buy
@ $9.9, valued at
$2.4M
Disposed/sold 110,000 options to buy
@ $14.92, valued at
$1.6M
Disposed/sold 120,000 options to buy
@ $9.07, valued at
$1.1M
Disposed/sold 120,000 options to buy
@ $3.72, valued at
$446.4k
Disposed/sold 40,000 restricted stock units
@ $16, valued at
$640k
|
|
| 08/31/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2009 |
4
| NICHOL GEOFFREY (Senior Vice President) has filed a Form 4 on MEDAREX INC |
| 02/26/2009 |
4
| NICHOL GEOFFREY (Sr. V. P. Product Development) has filed a Form 4 on MEDAREX INC |
|
|